cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of by 78c Enhanced NAD+, Alleviated Inflammation, Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens CD38-Induced Metabolic Dysfunction Primes Multiple
CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents Frontiers CD38 in Adenosinergic Pathways and Metabolic Re programming in Human Multiple Myeloma Cells: In tandem Insights From Basic Science to Therapy Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




